FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fiona Blackhall

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Physiology

Co-author Network

Publications

TOP 3
R Stovold; Kaye J Williams; M Babur; Fiona H Blackhall; J L Bryant; E J Dean; Caroline Dive; S L Meredith; A White
Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients.
Fiona H Blackhall; Richard Booton; Nick Thatcher; Keith Kerr
The impact on the multidisciplinary team of molecular profiling for personalized therapy in non-small cell lung cancer.
Alexander Molassiotis; Richard Wagland; Mari Lloyd Williams; Janelle Yorke; Chris D Bailey; Fiona H Blackhall; Richard Booton; Jackie Ellis; Jaclyn Smith
The Manchester cough in lung cancer scale: the development and preliminary validation of a new assessment tool.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fiona Blackhall (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: R Stovold; Kaye J Williams; M Babur; Fiona H Blackhall; J L Bryant; E J Dean; Caroline Dive; S L Meredith; A White
Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients.
British journal of cancer 2013;108(8):1704-11.
2013: Fiona H Blackhall; Richard Booton; Nick Thatcher; Keith Kerr
The impact on the multidisciplinary team of molecular profiling for personalized therapy in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2013;79(2):101-3.
2013: Alexander Molassiotis; Richard Wagland; Mari Lloyd Williams; Janelle Yorke; Chris D Bailey; Fiona H Blackhall; Richard Booton; Jackie Ellis; Jaclyn Smith
The Manchester cough in lung cancer scale: the development and preliminary validation of a new assessment tool.
Journal of pain and symptom management 2013;45(2):179-90.
2012: Jackie Ellis; Jemma Haines; Paul Lorigan; Chris D Bailey; Fiona H Blackhall; Richard Booton; Ann-Louise Caress; Jaclyn Smith; Carol Tishelman; Richard Wagland; Mari Lloyd Williams; Alexander Molassiotis
Considerations in developing and delivering a nonpharmacological intervention for symptom management in lung cancer: the views of patients and informal caregivers.
Journal of pain and symptom management 2012;44(6):831-42.
2012: Andrew A Vaughan; David C Wedge; Anthony D Whetton; J William Allwood; Fiona H Blackhall; Caroline Dive; Warwick B Dunn; Royston Goodacre
Liquid chromatography-mass spectrometry calibration transfer and metabolomics data fusion.
Analytical chemistry 2012;84(22):9848-57.
2012: Louise Carter; Caroline Dive; Fiona H Blackhall; Robert Metcalf; Matthew G Krebs
Biology and clinical relevance of circulating tumour cells.
Journal of thoracic disease 2012;4(5):453-5.
2012: Pek Keng Koh; Corinne Faivre-Finn; Fiona H Blackhall; Dirk De Ruysscher
Targeted agents in non-small cell lung cancer (NSCLC): clinical developments and rationale for the combination with thoracic radiotherapy.
Cancer treatment reviews 2012;38(6):626-40.
2012: Alex Molassiotis; Jaclyn Smith; Carol Tishelman; Richard Wagland; Mari Lloyd Williams; Ann Caress; Jackie Ellis; Richard Emsley; Jemma Haines; Paul Lorigan; Darren Ashcroft; Chris D Bailey; Fiona H Blackhall
Applying Best-Worst scaling methodology to establish delivery preferences of a symptom supportive care intervention in patients with lung cancer.
Lung cancer (Amsterdam, Netherlands) 2012;77(1):199-204.
2012: Amelie S M Harle; Fiona H Blackhall; Jaclyn Smith; Alexander Molassiotis
Understanding cough and its management in lung cancer.
Current opinion in supportive and palliative care 2012;6(2):153-62.
2012: Rachel Stovold; Fiona H Blackhall; Caroline Dive; JianMei Hou; Suzanne Meredith; Anne White
Biomarkers for small cell lung cancer: neuroendocrine, epithelial and circulating tumour cells.
Lung cancer (Amsterdam, Netherlands) 2012;76(3):263-8.
2012: Rovel Colaco; Linda Ashcroft; Fiona H Blackhall; Raffaele Califano; Paul Hulse; Paul Lorigan; Hamid Sheikh; Paul Taylor; Nicholas Thatcher; Corinne Faivre-Finn
Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial.
Lung cancer (Amsterdam, Netherlands) 2012;76(1):72-7.
2012: Jian-Mei Hou; Matthew G Krebs; Lee Lancashire; Karen Morris; Lynsey J C Priest; Robert Sloane; Rajeeb K Swain; Tim Ward; Cong Zhou; Alison Backen; Fiona H Blackhall; Alastair Greystoke; Caroline Dive
Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(5):525-32.
2012: Matthew G Krebs; Lee Lancashire; Daisuke Nonaka; Lynsey Priest; Malcolm Ranson; Robert Sloane; Tim Ward; Alison Backen; Fiona H Blackhall; Glen Clack; Jian-Mei Hou; Andrew Hughes; Caroline Dive
Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(2):306-15.
2012: L Khoja; M Krebs; Lia P Menasce; D Ryder; R Sloane; Juan W Valle; A Backen; Fiona H Blackhall; R Board; Glen Clack; Andrew Hughes; Caroline Dive
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.
British journal of cancer 2012;106(3):508-16.
2011: Hamid Sheikh; Paul Taylor; Nicholas Thatcher; Paul Lorigan; Linda Ashcroft; Fiona H Blackhall; Raffaele Califano; Rovel Colaco; Corinne Faivre-Finn
Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial.
Lung cancer (Amsterdam, Netherlands) 2011;74(1):75-9.
2011: David C Wedge; Anthony D Whetton; Lynsey Priest; Kathryn Simpson; Andrew A Vaughan; J William Allwood; Fiona H Blackhall; Marie Brown; Caroline Dive; Warwick Dunn; Royston Goodacre
Is serum or plasma more appropriate for intersubject comparisons in metabolomic studies? An assessment in patients with small-cell lung cancer.
Analytical chemistry 2011;83(17):6689-97.
2011: Matthew G Krebs; Robert Sloane; Lynsey Priest; Lee Lancashire; Jian-Mei Hou; Alastair Greystoke; Tim Ward; Roberta Ferraldeschi; Andrew Hughes; Glen Clack; Malcolm Ranson; Caroline Dive; Fiona H Blackhall
Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(12):1556-63.
2011: Emma J Dean; Jeff Cummings; Anne Roulston; Mark Berger; Malcolm Ranson; Fiona H Blackhall; Caroline Dive
Optimization of circulating biomarkers of obatoclax-induced cell death in patients with small cell lung cancer.
Neoplasia (New York, N.Y.) 2011;13(4):339-47.
2011: Richard H de Boer; Óscar Arrieta; Chih-Hsin Yang; Maya Gottfried; Valorie Chan; Johann Raats; Filippo de Marinis; Raymond P Abratt; Jürgen Wolf; Fiona H Blackhall; Peter Langmuir; Tsveta Milenkova; Jessica Read; Johan Vansteenkiste
Vandetanib plus pemetrexed for the second-line treatment of advanced non-small-cell lung cancer: a randomized, double-blind phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(8):1067-74.
2011: Luke R E Harrison; Dimitra Micha; Martin Brandenburg; Kathryn L Simpson; Christopher J Morrow; Olive Denneny; Cassandra Hodgkinson; Zaira Yunus; Clare Dempsey; Darren Roberts; Fiona H Blackhall; Guy Makin; Caroline Dive
Hypoxic human cancer cells are sensitized to BH-3 mimetic–induced apoptosis via downregulation of the Bcl-2 protein Mcl-1.
The Journal of clinical investigation 2011;121(3):1075-87.
2011: A Molassiotis; M Lowe; Fiona H Blackhall; Paul Lorigan
A qualitative exploration of a respiratory distress symptom cluster in lung cancer: cough, breathlessness and fatigue.
Lung cancer (Amsterdam, Netherlands) 2011;71(1):94-102.
2010: Matthew G Krebs; Tim Ward; Fiona H Blackhall; Jian-Mei Hou; Caroline Dive
Circulating tumour cells: their utility in cancer management and predicting outcomes.
Therapeutic advances in medical oncology 2010;2(6):351-65.
2010: P Wheatley-Price; Fiona H Blackhall; S-M Lee; C Ma; L Ashcroft; M Jitlal; W Qian; A Hackshaw; R Rudd; R Booton; S Danson; P Lorigan; N Thatcher; Frances A Shepherd
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(10):2023-8.
2010: Fiona H Blackhall; Mary O'brien; Peter Schmid; Marianne Nicolson; Paul Taylor; Tsveta Milenkova; Sarah J Kennedy; Nick Thatcher
A phase I study of Vandetanib in combination with vinorelbine/cisplatin or gemcitabine/cisplatin as first-line treatment for advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(8):1285-8.
2010: Aidalena Z Abidin; Raffaele Califano; Marina C Garassino; Amelie Harle; Fiona H Blackhall
Targeted therapies in small cell lung cancer: a review.
Therapeutic advances in medical oncology 2010;2(1):25-37.
2010: Alex Molassiotis; Jaclyn Smith; Mike I Bennett; Fiona H Blackhall; David Taylor; Burhan Zavery; Amelie Harle; Richard Booton; Elaine M Rankin; Mari Lloyd-Williams; Alyn H Morice
Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on cough.
Cough (London, England) 2010;6():9.
2009: Eitan Amir; Laszlo Mandoky; Fiona H Blackhall; Nick Thatcher; Walter Klepetko; Hendrik Jan Ankersmit; Mir Ali Reza Hoda; Gyula Ostoros; Magdolna Dank; Balazs Dome
Antivascular agents for non-small-cell lung cancer: current status and future directions.
Expert opinion on investigational drugs 2009;18(11):1667-86.
2009: Jian-Mei Hou; Alastair Greystoke; Lee Lancashire; Jeff Cummings; Tim Ward; Ruth Board; Eitan Amir; Sarah Hughes; Matthew Krebs; Andrew Hughes; Malcolm Ranson; Paul Lorigan; Caroline Dive; Fiona H Blackhall
Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy.
The American journal of pathology 2009;175(2):808-16.
2009: Roberta Ferraldeschi; Laura J Minchell; Steve Roberts; Simon Tobi; Kristen D Hadfield; Fiona H Blackhall; Saifee Mullamitha; Gregory Wilson; Juan Valle; Mark Saunders; William G Newman
UGT1A1*28 genotype predicts gastrointestinal toxicity in patients treated with intermediate-dose irinotecan.
Pharmacogenomics 2009;10(5):733-9.
2008: Lisa Rice; Charlotte E Waters; Jennifer Eccles; Helen Garside; Paula Sommer; Paul Kay; Fiona H Blackhall; Leo Zeef; Brian Telfer; Ian Stratford; Rob Clarke; Dave Singh; Adam Stevens; Anne White; David W Ray
Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor.
The Journal of endocrinology 2008;198(3):499-509.
2008: Ruth E Board; Victoria S Williams; Lucy Knight; Jacqueline Shaw; Alastair Greystoke; Malcolm Ranson; Caroline Dive; Fiona H Blackhall; Andrew Hughes
Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer.
Annals of the New York Academy of Sciences 2008;1137():98-107.
2008: Ruth E Board; Lucy Knight; Alastair Greystoke; Fiona H Blackhall; Andrew Hughes; Caroline Dive; Malcolm Ranson
DNA methylation in circulating tumour DNA as a biomarker for cancer.
Biomarker insights 2008;2():307-19.
2007: Suzanne K Lau; Paul C Boutros; Melania Pintilie; Fiona H Blackhall; Chang-Qi Zhu; Dan Strumpf; Michael R Johnston; Gail Darling; Shaf Keshavjee; Thomas K Waddell; Ni Liu; Davina Lau; Linda Z Penn; Frances A Shepherd; Igor Jurisica; Sandy D Der; Ming Tsao
Three-gene prognostic classifier for early-stage non small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(35):5562-9.
2007: Sylke Nagel; Raffaele Califano; Nicholas Thatcher; Fiona H Blackhall
Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer.
Expert opinion on pharmacotherapy 2007;8(18):3265-75.
2007: Emma J Dean; Malcolm Ranson; Fiona H Blackhall; Caroline Dive
X-linked inhibitor of apoptosis protein as a therapeutic target.
Expert opinion on therapeutic targets 2007;11(11):1459-71.
2007: Emma J Dean; Malcolm Ranson; Fiona H Blackhall; Sarah V Holt; Caroline Dive
Novel therapeutic targets in lung cancer: Inhibitor of apoptosis proteins from laboratory to clinic.
Cancer treatment reviews 2007;33(2):203-12.
2007: Anne C Armstrong; Fiona H Blackhall
Management of cancer from an unknown primary.
Expert opinion on pharmacotherapy 2007;8(4):445-55.
2007: Fiona H Blackhall; Frances A Shepherd
Small cell lung cancer and targeted therapies.
Current opinion in oncology 2007;19(2):103-8.
2006: Sofia Baka; C Manegold; E Buchholz; K Schott-von-Römer; Paul Lorigan; S Nagel; Fiona H Blackhall; L Aschroft; Nick Thatcher
Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;53(2):165-70.
2006: Sarit Aviel-Ronen; Fiona H Blackhall; Frances A Shepherd; Ming Tsao
K-ras mutations in non-small-cell lung carcinoma: a review.
Clinical lung cancer 2006;8(1):30-8.
2006: Fiona H Blackhall; Malcolm Ranson; Nick Thatcher
Where next for gefitinib in patients with lung cancer?
The lancet oncology 2006;7(6):499-507.
2006: Andrew R Clamp; Fiona H Blackhall; Audrey Henrioud; Gordon C Jayson; Kashi Javaherian; Jeffrey D Esko; John T Gallagher; Catherine L R Merry
The morphogenic properties of oligomeric endostatin are dependent on cell surface heparan sulfate.
The Journal of biological chemistry 2006;281(21):14813-22.
2006: Fiona H Blackhall; Sacha Howell; Bill Newman
Pharmacogenetics in the management of breast cancer -- prospects for individualised treatment.
Familial cancer 2006;5(2):151-7.
2005: Nick Thatcher; Corinne Faivre-Finn; Fiona H Blackhall; Heather Anderson; Paul Lorigan
Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13 Pt 2):5051s-5056s.
2005: Fiona H Blackhall; Pavlos I Papakotoulas; Sarah Danson; Nick Thatcher
Perspectives on novel therapies for bronchial carcinoma.
Expert opinion on pharmacotherapy 2005;6(7):1157-67.
2005: Fiona H Blackhall; Shazza Rehman; Nick Thatcher
Erlotinib in non-small cell lung cancer: a review.
Expert opinion on pharmacotherapy 2005;6(6):995-1002.
2005: Fiona H Blackhall; Jaishree Bhosle; Nick Thatcher
Chemotherapy for advanced non-small cell lung cancer patients with performance status 2.
Current opinion in oncology 2005;17(2):135-9.
2005: Fiona H Blackhall; Frances A Shepherd; Kathy S Albain
Improving survival and reducing toxicity with chemotherapy in advanced non-small cell lung cancer : a realistic goal?
Treatments in respiratory medicine 2005;4(2):71-84.
2005: Sarah Danson; Fiona H Blackhall; Paul Hulse; Malcolm Ranson
Interstitial lung disease in lung cancer: separating disease progression from treatment effects.
Drug safety : an international journal of medical toxicology and drug experience 2005;28(2):103-13.
2004: Fiona H Blackhall; Melania Pintilie; Dennis Wigle; Igor Jurisica; Ni Liu; Nikolina Radulovich; Michael R Johnston; Shaf Keshavjee; Ming Tsao
Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection.
Neoplasia (New York, N.Y.) 2004;6(6):761-7.
2004: Fiona H Blackhall; Dennis Wigle; Igor Jurisica; Melania Pintilie; Ni Liu; Gail Darling; Michael R Johnston; Shaf Keshavjee; Thomas K Waddell; Timothy Winton; Frances A Shepherd; Ming Tsao
Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study.
Lung cancer (Amsterdam, Netherlands) 2004;46(2):197-204.
2004: Fiona H Blackhall; Frances A Shepherd
Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer.
Hematology/oncology clinics of North America 2004;18(5):1121-41, ix.
2004: Jiang Liu; Fiona H Blackhall; Isolde Seiden-Long; Igor Jurisica; Roya Navab; Ni Liu; Nikolina Radulovich; Dennis Wigle; Mujahid Sultan; Jim Hu; Ming Tsao; Michael R Johnston
Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasis.
Oncogene 2004;23(37):6316-24.
2004: E June Davies; Fiona H Blackhall; Jonathan H Shanks; Guido David; Alan T McGown; Ric Swindell; Richard J Slade; Pierre Martin-Hirsch; John T Gallagher; Gordon C Jayson
Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5178-86.
2004: Chang-Qi Zhu; Fiona H Blackhall; Melania Pintilie; Pratibha Iyengar; Ni Liu; James Ho; Taylor Chomiak; Davina Lau; Timothy Winton; Frances A Shepherd; Ming Tsao
Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1984-91.
2003: Andrew R Clamp; Fiona H Blackhall; Paul A Vasey; M Soukop; Rob Coleman; Gavin Halbert; L Robson; Gordon C Jayson
A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma.
British journal of cancer 2003;89(7):1152-4.
2003: Fiona H Blackhall; Catherine L R Merry; Malcolm Lyon; Gordon C Jayson; Judah Folkman; Kashi Javaherian; John T Gallagher
Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates.
The Biochemical journal 2003;375(Pt 1):131-9.
2003: Shirley M-H Sy; Nathalie Wong; Tony Shu Kam Mok; Ming Tsao; Tak Wai Lee; Gary Tse; Fiona H Blackhall; Philip J Johnson; Anthony P Yim
Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicity.
Lung cancer (Amsterdam, Netherlands) 2003;41(1):91-9.
2003: Fiona H Blackhall; Melania Pintilie; Michael Michael; Natasha B Leighl; Ronald Feld; Ming Tsao; Frances A Shepherd
Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2241-7.
2002: Fiona H Blackhall; A D Atkinson; M B Maaya; W D J Ryder; Greg Horne; Daniel R Brison; Brian A Lieberman; John A Radford
Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease.
British journal of cancer 2002;87(4):381-4.
2001: Fiona H Blackhall; Catherine L R Merry; E J Davies; Gordon C Jayson
Heparan sulfate proteoglycans and cancer.
British journal of cancer 2001;85(8):1094-8.
2001: Fiona H Blackhall; Malcolm Ranson; John A Radford; B W Hancock; M Soukop; Alan T McGown; A Robbins; Gavin Halbert; Gordon C Jayson
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma.
British journal of cancer 2001;84(4):465-9.
2000: PS Sengupta; Alan T McGown; V Bajaj; Fiona H Blackhall; Ric Swindell; M Bromley; Jonathan H Shanks; Tim Ward; CH Buckley; K Reynolds; Richard J Slade; Gordon C Jayson
p53 and related proteins in epithelial ovarian cancer.
European journal of cancer (Oxford, England : 1990) 2000;36(18):2317-28.